In the construction of large antibody libraries by in vivo recombination, two non-homogeneous loxP sites are required for the exchange of V genes between phagemids to create many new V H -V L combinations. The mutated loxP511 was designed not to recombine with the wild-type loxP (loxPwt) in early studies and a combination of the two has been used to construct antibody libraries. But recent reports have shown that recombination occurs between loxPwt and loxP511. This suggests that the combinational use of loxP511 and loxPwt might lead to the loss of the V gene diversity of antibody libraries. Therefore, it is necessary to find a new combination of loxPs to avoid the excision recombination in the antibody library. In this study, we found that the excision recombination between loxP511 and loxP2272, another mutated loxP sequence, was undetectable within one phagemid, while the excision recombination between loxP511 and loxPwt occurred at a frequency of 40%, higher than that reported previously. Furthermore, the in vivo recombination of different phagemids with loxP511 and loxP2272 showed that the V gene exchange was efficiently mediated to produce new V H -V L combinations. It was concluded that the loxP511 and loxP2272 combination was more favorable for reducing the excision recombination and constructing large phage antibody libraries with high diversity.
Phage display was developed as a means of constructing antibody libraries in vitro [1] . In general, the quality of the antibodies isolated is dependent on the size of the library used for selection. Thus, large libraries have become important sources for obtaining high-affinity antibodies [2] . Recombination has been proposed as an alternative to cloning for the construction of large phage antibody libraries. The most used site-specific recombination system is loxP/Cre [3] . This system includes Cre recombinase, which mediates the recombination between two 34 bp loxP sites, and it does not require any accessory factors. A loxP site contains an asymmetric 8 bp core region flanked by two 13 bp palindromic sequences.
However, the use of the loxP/Cre system is limited by the availability of only one loxP sequence. The mutated loxP511 sequence has been identified to efficiently recombine with itself, but not with loxPwt as shown in early studies [4] . The combination of loxPwt and loxP511 has been used for constructing large antibody libraries [5, 6] , one of which was calculated to have a size of up to 3×10 11 . This was achieved by creating a relatively small primary library in a phagemid vector in which the V H and V L genes were separated by these incorporated loxP sites. The V H and V L genes in this primary library were then recombined by infecting the phages into Cre-expressing bacteria at a high multiplicity of infection (MOI [7, 8] . This suggests that the V gene between loxP511 and loxPwt might be deleted by excision recombination within phagemids, when the new V H -V L combinations were created by recombination between different phagemids in Cre-expressing bacteria. The phagemids with no inserts between loxP sites can also be packaged in phages and thus contribute to the size, but not the diversity, of antibody libraries. This means that the antibody libraries constructed by the phagemid vector with loxP511 and loxPwt might have relatively low diversity, although they are large in size. To avoid the loss of V gene diversity resulting from excision recombination, loxPwt was replaced by a mutated loxP sequence, loxP2272 [9] , which has been identified in recent studies [8] to recombine with itself efficiently, but rarely with loxP511. The results show that loxP511 recombined with loxPwt at a relatively higher frequency than that reported previously, and that the recombination between loxP511 and loxP2272 was undetectable. Furthermore, the V genes in the phagemid vector with loxP511 and loxP2272 can be exchanged efficiently while being mediated by Cre recombinase. All these results indicate that the combinational use of loxP511 and loxP2272 can reduce the excision recombination and can be used to construct phage antibody libraries with high diversity.
Experimental Procedures
Primers used were listed in Table 1 .
To construct pIT2-loxP511/wt, the standard linker of scFv in the phagemid antibody display vector pIT2, which was provided by Dr. Greg WINTER (Medical Research Council, Cambridge, UK), was replaced by the loxP511 linker initially. The loxP511 linker was obtained by annealing two complementary oligonucleotides (loxP511 linker-b and loxP511 linker-f) with the cohesive end of SalI forming at 5' and SacI at 3', and subsequently cloning the annealed product into the pIT2 phagemid that was digested by SalI/SacI to produce pIT2-loxP511. Then, the gIII-loxPwt fusing gene was obtained by PCR using pIT2 DNA as the template and the primer gIIIloxPwt, which included the loxPwt site at the 3' end, and pelB. The amplified product was subsequently digested by NotI and EcoRI, and cloned into pIT2-loxP511. The loxPwt site was replaced by the loxP2272 site, which was also incorporated by PCR using the primer gIIIloxP2272 as described above to produce pIT2-loxP511/ 2272 ( Fig. 1) . Based on pIT2-antiBSA and pIT2-antiUBI, which contained anti-bovine serum albumin scFv and anti-bovine ubiquitin scFv respectively, two kinds of pIT2-loxP511/2272 constructs, pIT2-antiBSA-loxP511/ 2272 and pIT2-antiUBI-loxP511/2272, were created as described above.
The plasmid containing the Cre gene was kindly provided by Prof. Yi-Ping HU (Department of Cell Biology, Second Military Medical University, Shanghai, China). The Cre gene was amplified with the Cre plasmid DNA as a template and using the primers Cre-back and Cre-for, so that the EcoRI and XhoI sites were introduced into 5' and 3' ends of the Cre-encoding sequence, respectively. The amplified Primer Sequence
Cre-back
5'-CGAATTCGGTGCCCAAGAAGAAG-3'
Cre-for 5'-GCTCGAGTCAGTCCCCATCCTCG-3' Cre fragment was digested by EcoRI and XhoI, and subsequently cloned into pBT (Invitrogen, Carlsbad, CA, USA) to produce pBT-Cre. The TG1(Cre), which expresses Cre recombinase, was obtained by transfecting Escherichia coli TG1 with pBT-Cre.
To test the excision recombination inside phagemids, pIT2-loxP511/wt or pIT2-loxP511/2272 was transfected into the Cre-expressing bacteria BS1365, which was a gift from Dr. Brian SAUER (Stowers Institute for Medical Research, Kansas City, MO, USA). Cells were cultured in 2×TY, 1% glucose, 100 µg/ml ampicillin, 100 µg/ml kanamycin at 37 °C overnight for recombination. Phagemids from these cells were then digested with EcoRI and subjected to agarose electrophoresis. To estimate the excision recombination rate, BS1365 cells with "recombined phagemids" were diluted (1:20) in the above medium, and grown at 37 °C until A 600 reached 0.5. Helper phages were added and the medium was allowed to stand without shaking for 1 h at 37 °C. Bacteria were then collected by centrifugation and resuspended in the same medium except that the glucose concentration was 0.1%. After being cultured overnight, the "recombined phages" were purified, and allowed to infect TG1 (A 600 =0.5) at an MOI of 1. The cells were plated on TYE agar containing 100 µg/ml ampicillin and 1% glucose at serial dilutions. After being cultured at 37 °C overnight, 10 individual clones were picked. To confirm the excision recombination inside the phagemids, the "recombinant phagemids" were digested by another restriction enzyme BamHI. There are two BamHI sites in the pIT2-loxP511/ wt or pIT2-loxP511/2272, one is between the loxP sites. If there is no recombination, two bands (5.5 kb and 0.9 kb) will be seen. On the contrary, if there is excision recombination, only one band (4.5 kb) will be revealed because one of the BamHI sites was lost.
To test the exchange of V genes between pIT2-loxP511/2272 phagemids, the phages containing anti-BSA scFv or anti-UBI scFv were created and quantified. To induce recombination, TG1(Cre) cells were grown in 2×TY medium with 170 µg/ml chloromycin (because the pBT-Cre displays chloromycin resistance) and 1% glucose at 37 °C until A 600 reached 0.5. Phages containing different scFv genes were mixed in equal quantity and allowed to infect TG1(Cre) at an MOI of 20 for 1 h at 37 °C without shaking. Ampicillin was then added to a final concentration of 100 µg/ml. After being cultured at 37 °C overnight for recombination, "recombined phages" were collected and used to re-infect TG1 as described above. Ten clones were picked and the V gene of each was tested by PCR using the primers pHEN and antiBSA-V H or antiUBI-V H to amplify the V H gene, or the primers pelB and antiBSA-V L or antiUBI-V L to amplify V L (Fig.  2) . Depending on which kind of V gene, V H or V L , could be amplified in each clone, the V H -V L combination was identified. Recombination between different phagemids can produce new combinations of
Results and Discussion
The loxP511 was inserted between V H and V L genes as a linker, and the loxPwt or loxP2272 was placed at the 3' end of gIII in the phagemid pIT2 to obtain pIT2-loxP511/wt or pIT2-loxP511/2272. The effect of the translated loxP511 site on the function of scFv was estimated by the activity assay of antiBSA scFv derived from the phagemid pIT2-antiBSA-loxP511/wt or pIT2-antiBSA-loxP511/2272. The results showed that there was no functional change in the new antiBSA scFv compared with the original one (data not shown).
To compare the excision recombination rate of the phagemid vector with loxP511-loxP2272 and loxP511-loxPwt combinations, the "recombined phagemids" were digested with EcoRI. No abnormal small band was seen for pIT2-loxP511/2272, while an abnormal small band was observed for pIT2-loxP511/wt [ Fig. 3(A) ]. This indicated Fig. 1 Diagram of vector pIT2-loxP511/2272
Enzyme sites SacI and SalI, and NotI and EcoRI were used for loxP511 and loxP2272 cloning, respectively. EcoRI and BamHI were used for the analysis of excision recombination.
that excision recombination did occur not in pIT2-loxP511/ 2272, but in pIT2-loxP511/wt. Thereafter, the excision recombination rate was estimated by digesting 10 individual clones of "recombined phagemids" with BamHI. Four of 10 clones from pIT2-loxP511/wt were observed to have excision recombination [ Fig. 3(B) ], but no clone from pIT2-loxP511/2272 showed excision recombination [ Fig.  3(C) ]. The deletion of the sequence between the two loxP sites was verified by DNA sequencing. The excision recombination mediated by loxP511 and loxPwt occurred at a frequency of about 40%, which is much higher than what was reported previously [7, 8] , while the recombination of loxP511 and loxP2272 could not be detected. Because the phagemids without the sequence between the loxP sites can also be packed in phages, the loss of diversity of scFv may occur even with a large library size when the combination of loxPwt and loxP511 is used to construct phage display antibody libraries. Therefore, it is suggested that the replacement of loxPwt by loxP2272 may reduce the excision recombination and prevent the loss of diversity.
While excision recombination was rarely found in the phagemid with loxP511 and loxP2272, the ability of these incorporated mutated loxP sites to shuffle V genes between phagemids was then tested by using pIT2-antiBSAloxP511/2272 and pIT2-antiUBI-loxP511/2272 in TG1(Cre) as a model. First, the plasmid pBT-Cre, which had a different replicon and resistance from pIT2, was constructed and transfected into TG1 to obtain TG1(Cre). The activity of Cre recombinase in TG1(Cre) was identi- http://www.abbs.info; www.blackwellpublishing.com/abbs fied by the occurrence of excision recombination in pIT2-loxP511/wt, and the recombination rate was approximately the same as that in BS1365 (data not shown). Then, the phages containing different scFvs were allowed to co-infect TG1(Cre). The V H and V L genes of "recombined phagemid" clones were identified by PCR using the primers antiBSA-V H and antiBSA-V L or antiUBI-V H and antiUBI-V L which were located at CDR3(s) of the V genes of anti-BSA or anti-UBI scFv, respectively. From the PCR results, 5 out of 10 clones were identified to have new V H -V L combinations. Two of these clones had the V H /antiBSA-V L /antiUBI combination, while the other three had the V H /antiUBI-V L /antiBSA combination (Fig.  4) . Our results showed that the V gene can be exchanged efficiently between phagemids to form new scFvs in the loxP511-loxP2272/Cre system. In summary, it has been shown that the phagemid vector with loxP511 and loxP2272 not only reduced the excision recombination when compared to that with loxP511 and loxPwt, which has been used for the construction of phage antibody libraries, but also successfully exchanged the V genes of scFv between phagemids in Cre-expressing bacteria, and facilitated the creation of new V H -V L combinations. Therefore, the new phagemid vector containing the loxP511-loxP2272 combination instead of the loxP511-loxPwt combination may be more efficient in constructing phage display antibody libraries with high diversity.
Fig. 3
Restriction enzyme digestion analysis of excision recombination pIT2-loxP511/wt and pIT2-loxP511/2272 were transfected into BS1365 in turn. The "recombined phagemids" were digested with EcoRI. (A) pIT2-loxP511/wt produced two bands because of excision recombination (lane a), whereas pIT2-loxP511/2272 only produced one band (lane b). (B) To estimate the rate of excision recombination, 10 individual clones (lanes 1-10) of "recombined phagemids" were digested with BamHI. The recombined clone was identified by the single band displayed after BamHI digestion, while the non-recombined clone displayed two bands. Recombination was detected in 4 out of 10 clones from pIT2-loxP511/wt. (C) No recombination was detected in the clones from pIT2-loxP511/2272. M, marker.
Fig. 4
Identification of the V gene in recombined phagemids by PCR
